Avalon Pharmaceuticals Receives NASDAQ Deficiency Notice
Avalon Pharmaceuticals Receives NASDAQ Deficiency Notice
0 posts Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced that on November 20, 2008 it received a Deficiency Notice from The NASDAQ Stock Market, LLC notifying the Company that it is not in …
Add A Comment